Last reviewed · How we verify

NCT03565146

Evaluation of the Efficacy and Safety of PiQo4 System for the Treatment of Pigmented Lesions

Completed NA Last updated 27 December 2019
What this trial tests

NA trial testing PiQo4 Laser System in Pigmentation in 25 participants. Completed in 5 June 2019.

Timeline
29 June 2018
Primary endpoint
5 June 2019
5 June 2019

Quick facts

Lead sponsorFocus Medical, LLC
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationna
Designsingle group
Maskingnone
Primary purposetreatment
Enrollment25
Start date29 June 2018
Primary completion5 June 2019
Estimated completion5 June 2019
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

Focus Medical, LLC

Who can join

Adults 21 to 70, any sex, with Pigmentation. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

A total of at least 25 healthy subjects at a single site, aged 21-70 years old with congenital or acquired challenging/resistant, age/sun-related flat and benign facial pigmentation with or without hand pigmentation who wish to improve their skin appearance.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of PiQo4 Laser System

Trials testing the same drug.

Other recruiting trials for Pigmentation

Currently open trials in the same condition.

Other Focus Medical, LLC trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03565146.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing